Research News

NIH – Emergency Award: RADx-UP – Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)

Purpose: High rates and disparities of COVID-19 infection, morbidity, and mortality continue among underserved and vulnerable populations across the United States. The overarching goal of the Rapid Acceleration of Diagnostics for Underserved…

NIH – Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)

Purpose: The National Institutes of Health (NIH) has released two new funding opportunities to address chronic diseases and health disparities in the nation. These funding opportunities are a direct result…

NIH – Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)

Purpose: This funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research…

Wellcome Leap – $55M Delta Tissue Program

Purpose We need a new platform – a ‘tissue time machine’ – that can profile tissue states and predict transitions between states (‘Delta Tissue’ or ‘ΔT’). The platform would provide…

NIH – Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell therapies for type 1 diabetes (T1D). The purpose is…

NIH – BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)

Purpose: This FOA solicits applications for research projects that seek to understand how circuit activity gives rise to mental experience and behavior using innovative, methodologically-integrated approaches. The goal is to…

NIH – Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)

Purpose: The overarching goal of this funding opportunity announcement (FOA) for the Common Fund program “Illuminating the Druggable Genome” (IDG;https://commonfund.nih.gov/idg/ is to solicit applications to build a set of Cutting Edge…

NIH – Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) and related RFAs

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to utilize implementation science to develop, implement, and evaluate creative, multidisciplinary approaches to healthcare delivery that more effectively engage and…

Milken Institute Center for Strategic Philanthropy – Bipolar Disorder Grants

Purpose: The Milken Institute, in collaboration with the Baszucki Brain Research Fund is administering a grant program focused on bipolar disorder. The Fund intends to award up to ten research…

Crohn’s and Colitis Foundation

Purpose: The Crohn’s & Colitis Foundation is seeking academic researchers to apply to the international request for proposals (RFP) to gain access to IBD patients’ biosamples and/or research-ready datasets housed…

American Diabetes Association

Purpose: The American Diabetes Association (ADA) is pleased to announce a new Request for Applications (see RFA) focused on the impact of diabetes on health disparities and, the impact of…

NIH – Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)

Purpose: This initiative will support (1) observational research to understand the role of structural racism and discrimination (SRD) in causing and sustaining health disparities, and (2) intervention research that addresses…

NIH – Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)

Purpose: The Transformative Research to Address Health Disparities and Advance Health Equity initiative is soliciting applications to support collaborative investigative teams or individual scientists who propose unusually innovative research projects,…

NIH – High-Priority Behavioral and Social Research Networks in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R24 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) invites applications to develop new research and research infrastructure via networks for behavioral and social research on Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD);…

NIH – Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acquisition, management, analysis, visualization, and dissemination…

NIH – The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) encourages applications from institutions and organizations proposing original research aimed at the characterization of the function of neoepitopes and neoantigens in type 1 diabetes.…

DOD – Peer Reviewed Medical Research Program Solicitations

Purpose: The Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) released its fiscal year (FY) 2021 Peer Reviewed Medical Research Program (PRMRP) solicitations.  For FY 2021, Congress has…

AHRQ/PCORI Learning Health System Small Grant Pilot Program (R03)

Purpose: The Agency for Healthcare Research and Quality (AHRQ), in partnership with the Patient-Centered Outcomes Research Institute (PCORI), invites applications for funding to support innovative patient-centered outcomes research small pilot…

2022 Vilcek Prizes for Creative Promise in Biomedical Science

Purpose: The Vilcek Foundation will award three Creative Promise Prizes of $50,000 each to young, immigrant biomedical scientists who demonstrate outstanding early achievement. Key Dates: Applications are open through June…

NIH – Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Purpose: This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific…

NIH – Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes. (U01) Clinical Trials Not Allowed

Purpose: The purpose of this funding opportunity is to expand on the FDA’s modeling efforts to more comprehensively address fentanyl, stimulants and polysubstance use and their interactive effects on opioids use,…

NIH – Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)

Purpose: The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD mechanistic research. Background: This…

NIH – Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)

Purpose: This Funding Opportunity Announcement (FOA) invites applications for clinical or community sites to be part of a multi-center group- or cluster-randomized trial under the Early Intervention to Promote Cardiovascular…

National MS Society – Detecting Multiple Sclerosis Before the Onset of Neurological Deficits

Purpose: This RFA is intended to support knowledge generation that will eventually lead to early detection of MS at the individual level. The RFA does not include funds to start…

NIH – Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)

Purpose: This initiative will support the engineering of immune cells to target the human pancreatic compartment to report on previously inaccessible information about diabetes initiation and progression, and/or to deliver…